The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Reid, H. M., & Kinsella, B. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309314200 · Cited by 56
RetractedReid, H. M., & Kinsella, B. T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a116.309314 · Cited by 55
RetractedRho GTPases and the Actin Cytoskeleton
Hall, A. (1998) · Science · doi:10.1126/science.279.5350.509 · Cited by 6,140
Inositol Trisphosphate, a Novel Second Messenger in Cellular Signal Transduction
Berridge, M. J., & Irvine, R. F. (1984) · Nature · doi:10.1038/312315a0 · Cited by 6,086
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Hamberg, M., Svensson, J., & Samuelsson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,045
Turnover of Inositol Phospholipids and Signal Transduction
Nishizuka, Y. (1984) · Science · doi:10.1126/science.6147898 · Cited by 1,614
Eikelboom, J. W., Hirsh, J., Weitz, J. I., Johnston, M., Yi, Q., & Yusuf, S. (2002) · Circulation · doi:10.1161/01.cir.0000013777.21160.07 · Cited by 1,053
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 937
p115 RhoGEF, a GTPase Activating Protein for Gα 12 and Gα 13
Kozasa, T., Jiang, X., Hart, M. J., Sternweis, P. M., Singer, W. D., Gilman, A. G., Bollag, G., & Sternweis, P. C. (1998) · Science · doi:10.1126/science.280.5372.2109 · Cited by 854
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
Isoprostanes: markers and mediators of oxidative stress
Montuschi, P., Barnes, P. J., & Roberts, L. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-2330rev · Cited by 747
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 684
Roles of G‐protein‐coupled receptor dimerization: From ontogeny to signalling regulation
Terrillon, S., & Bouvier, M. (2004) · EMBO reports · doi:10.1038/sj.embor.7400052 · Cited by 683
Needleman, P., Moncada, S., Bunting, S., Vane, J. R., Hamberg, M., & Samuelsson, B. (1976) · Nature · doi:10.1038/261558a0 · Cited by 526
Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C
Offermanns, S., & Simon, M. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15175 · Cited by 498
Offermanns, S., Laugwitz, K. L., Spicher, K., & Schultz, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.504 · Cited by 465
Gβγ Subunits Mediate Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor
Luttrell, L. M., Rocca, G. J. D., van Biesen, T., Luttrell, D. K., & Lefkowitz, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4637 · Cited by 457
O'Dowd, B. F., Hnatowich, M., Regan, J. W., Leader, W. M., Caron, M. G., & Lefkowitz, R. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37546-x · Cited by 406
Thromboxanes: Selective Biosynthesis and Distinct Biological Properties
Needleman, P., Minkes, M. S., & Raz, A. (1976) · Science · doi:10.1126/science.945611 · Cited by 388
Shenker, A., Goldsmith, P., Unson, C. G., & Spiegel, A. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31586-2 · Cited by 376
Kobayashi, T., Tahara, Y., Matsumoto, M., Iguchi, M., Sano, H., Murayama, T., Arai, H., Oida, H., Yurugi-Kobayashi, T., Yamashita, J. K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421446 · Cited by 373
Raychowdhury, M. K., Yukawa, M., Collins, L. J., McGrail, S. H., Kent, K. C., & Ware, J. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32161-0 · Cited by 357
Provision of medicine in Ecuador.
Johnston, T. (1980) · The Lancet · Cited by 314
Hirata, T., Ushikubi, F., Kakizuka, A., Okuma, M., & Narumiya, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118518 · Cited by 301
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.
Daniel, T. O., Liu, H., Morrow, J. D., et al. (1999) · PubMed · Cited by 295
Ahn, S., Nelson, C. D., Garrison, T. R., Miller, W. E., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262789099 · Cited by 239
Vignola, A. M., Mirabella, F., Costanzo, G., Di Giorgi, R., Gjomarkaj, M., Bellia, V., & Bonsignore, G. (2003) · Chest · doi:10.1378/chest.123.3_suppl.417s · Cited by 237
Overview of physiological and pathophysiological effects of thromboxane A2.
Ogletree, M. L. (1987) · PubMed · Cited by 220
Haurand, M., & Ullrich, V (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95702-9 · Cited by 191
Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity
Kabashima, K., Murata, T., Tanaka, H., Matsuoka, T., Sakata, D., Yoshida, N., Katagiri, K., Kinashi, T., Tanaka, T., Miyasaka, M., et al. (2003) · Nature Immunology · doi:10.1038/ni943 · Cited by 191
Wilson, D. P., Susnjar, M., Kiss, E., Sutherland, C., & Walsh, M. P. (2005) · Biochemical Journal · doi:10.1042/bj20050237 · Cited by 189
Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor
GUERRERO, J. A., LOZANO, M. L., CASTILLO, J., BENAVENTE‐GARCÍA, O., VICENTE, V., & RIVERA, J. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.01099.x · Cited by 187
Internalization of the TXA2 Receptor α and β Isoforms
Parent, J.-L., Labrecque, P., Orsini, M. J., & Benovic, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8941 · Cited by 178
Evidence That Phospholipase δ1 Is the Effector in the Gh (Transglutaminase II)-mediated Signaling
Feng, J.-F., Rhee, S. G., & Im, M.-J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16451 · Cited by 178
G alpha 13 stimulates Na-H exchange.
Voyno-Yasenetskaya, T., Conklin, B. R., Gilbert, R. L., Hooley, R., Bourne, H. R., & Barber, D. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37604-4 · Cited by 175
Biochemical evidence of platelet activation in patients with persistent unstable angina
Hamm, C. W., Lorenz, R. L., Bleifeld, W., Kupper, W., Wober, W., & Weber, P. C. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80336-4 · Cited by 175
Kinsella, B. T., O’Mahony, D. J., & FitzGerald, G. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36684-4 · Cited by 172
Mouse thromboxane A2 receptor: cDNA cloning, expression and Northern blot analysis
Namba, T., Sugimoto, Y., Hirata, M., Hayashi, Y., Honda, A., Watabe, A., Negishi, M., Ichikawa, A., & Narumiya, S. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80009-9 · Cited by 161
Kinsella, B. T., O’Mahony, D. J., & FitzGerald, G. A. (1997) · PubMed · Cited by 160
Lefer, A. M., Smith, E. F., Araki, H., Smith, J. B., Aharony, D., Claremon, D. A., Magolda, R. L., & Nicolaou, K. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1706 · Cited by 155
Thromboxane A2 and prostaglandin F2α mediate inflammatory tachycardia
Takayama, K., Yuhki, K., Ono, K., Fujino, T., Hara, A., Yamada, T., Kuriyama, S., Karibe, H., Okada, Y., Takahata, O., et al. (2005) · Nature Medicine · doi:10.1038/nm1231 · Cited by 152
Lumley, P., White, B. P., & Humphrey, P. P. A. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb12017.x · Cited by 148
Nakashima, S., Koike, T., & Nozawa, Y. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11014-6 · Cited by 146
Characterization and chromosomal mapping of the human thromboxane A2 receptor gene.
Nüsing, R. M., Hirata, M., Kakizuka, A., Eki, T., Ozawa, K., & Narumiya, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74595-5 · Cited by 138
Phosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human Platelets
Habib, A., FitzGerald, G. A., & Maclouf, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2645 · Cited by 136
Ushikubi, F., Aiba, Y., Nakamura, K., Namba, T., Hirata, M., Mazda, O., Katsura, Y., & Narumiya, S. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1825 · Cited by 131
Differential Signaling by the Thromboxane Receptor Isoforms via the Novel GTP-binding Protein, Gh
Vezza, R., Habib, A., & FitzGerald, G. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12774 · Cited by 131
Miggin, S. M., & Kinsella, B. T. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00109-3 · Cited by 131
Knezevic, I., Borg, C., & Breton, G. C. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74486-x · Cited by 125
KATUGAMPOLA, S. D., & Davenport, A. P. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704416 · Cited by 117
Li, Y., Kang, J. X., & Leaf, A. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00122-6 · Cited by 116
Morinelli, T. A., Zhang, L. M., Newman, W. H., & Meier, K. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37516-6 · Cited by 110
Thromboxanes: Synthase and Receptors
Shen, R., & Tai, H. (1998) · Journal of Biomedical Science · doi:10.1007/bf02253465 · Cited by 108
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis
Dogné, J., Hanson, J., & Praticò, D. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.001 · Cited by 108
Wilson, S. J., Roche, A. M., Kostetskaia, E., & Smyth, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405002200 · Cited by 108
Ishizuka, T., Kawakami, M., Hidaka, T., Matsuki, Y., Takamizawa‐Matsumoto, M., Suzuki, K., Kurita, A., & Nakamura, H. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00614.x · Cited by 107
Arora, K. K., Krsmanović, L. Z., Mores, N., O'Farrell, H., & Catt, K. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25581 · Cited by 106
Walsh, M., Foley, J. F., & Kinsella, B. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907881199 · Cited by 105
Ashton, A. W., & Ware, J. A. (2004) · Circulation Research · doi:10.1161/01.res.0000138300.41642.15 · Cited by 100
Abe, T., Takeuchi, K., Takahashi, N., TSUTSUMI, E., Taniyama, Y., & Abe, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118108 · Cited by 96
Funk, C. D., Furci, L., Moran, N. M., & FitzGerald, G. A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13289-6 · Cited by 94
Dorn, G. W., Liel, N., Trask, J. L., Mais, D. E., Assey, M. E., & Halushka, P. V. (1990) · Circulation · doi:10.1161/01.cir.81.1.212 · Cited by 93
Gao, Y., Tang, S., Zhou, S., & Ware, J. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38764-6 · Cited by 90
Selective Activation of Effector Pathways by Brain-specific G Protein β5
Zhang, S., Coso, O. A., Lee, C., Gutkind, J. S., & Simonds, W. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33575 · Cited by 88
Studer, R. K., Negrete, H. O., Craven, P. A., & DeRubertis, F. R. (1995) · Kidney International · doi:10.1038/ki.1995.310 · Cited by 87
PGH2, TxA2 and PGI2 have potent and differentiated actions on human uterine contractility
Wilhelmsson, L., Wikland, M., & Wiqvist, N. (1981) · Prostaglandins · doi:10.1016/0090-6980(81)90145-3 · Cited by 77
Gβ5γ2 Is a Highly Selective Activator of Phospholipid-dependent Enzymes
Maier, U., Babich, A., Macrez, N., Leopoldt, D., Gierschik, P., Illenberger, D., & Nürnberg, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13746 · Cited by 74
Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets
Hanasaki, K., & Arita, H. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90266-6 · Cited by 74
Miggin, S. M., & Kinsella, B. T. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00103-3 · Cited by 74
Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis.
Mehta, J. L., Lawson, D., Mehta, P., & Saldeen, T. G. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4511 · Cited by 73
Unresponsiveness of Platelets Lacking Both Gαq and Gα13
Moers, A., Wettschureck, N., Grüner, S., Nieswandt, B., & Offermanns, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408962200 · Cited by 68
Hamelin, E., Thériault, C., Laroche, G., & Parent, J.-L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503438200 · Cited by 67
Provocation With Adenosine 5′-Monophosphate Increases Sputum Eosinophils
van den Berge, M., Kerstjens, H. A. M., de Reus, D. M., Kauffman, H. F., Koëter, G. H., & Postma, D. S. (2003) · CHEST Journal · doi:10.1378/chest.123.3_suppl.417s-a · Cited by 66
Martin, C., Uhlig, S., & Ullrich, V. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.2.3545 · Cited by 64
Capra, V., Veltri, A., Foglia, C., Crimaldi, L., Habib, A., Parenti, M. D., & Rovati, G. E. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001487 · Cited by 61
Ohkubo, S., Nakahata, N., & Ohizumi, Y. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16702.x · Cited by 60
Self-citationBorg, C., Lim, C. T., Yeomans, D. C., Dieter, J. P., Komiotis, D., Anderson, E. G., & Breton, G. C. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37576-2 · Cited by 58
Rochdi, M. D., Laroche, G., Dupré, É., Giguère, P. M., Lebel, A., Watier, V., Hamelin, É., Lépine, M., Dupuis, G., & Parent, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312621200 · Cited by 55
Effects of the thromboxane A2 mimetic, U46,619, on pulmonary vagal afferents in the cat
Karla, W., Shams, H., Orr, J. A., & Scheid, P. (1992) · Respiration Physiology · doi:10.1016/0034-5687(92)90019-s · Cited by 54
From the Design to the Clinical Application of Thromboxane Modulators
Dogné, J., Hanson, J., de Leval, X., Praticò, D., Pace-Asciak, C. R., Drion, P. V., Pirotte, B., & Ruan, K. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776055921 · Cited by 54
Wilson, S. J., Dowling, J. K., Zhao, L., Carnish, E. R., & Smyth, E. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000252667.53790.4e · Cited by 53
Thromboxane receptor blockade reduces renal injury in murine lupus nephritis
Spurney, R. F., Fan, P.-Y., Ruiz, P., Sanfilippo, F. P., Pisetsky, D. S., & Coffman, T. M. (1992) · Kidney International · doi:10.1038/ki.1992.149 · Cited by 50
Walsh, M. T., Foley, J. F., & Kinsella, B. T. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37684-0 · Cited by 48
Laroche, G., Lépine, M., Thériault, C., et al. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.02.008 · Cited by 47
Ashton, A. W., Ware, G. M., Kaul, D. K., & Ware, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210766200 · Cited by 46
Iwashita, M., Oka, N., Ohkubo, S., Saito, M., & Nakahata, N. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.073 · Cited by 44
Self-citationcDNA cloning of a thromboxane A2 receptor from rat astrocytes
Kitanakaa, J.-I., Hashimoto, H., Sugimoto, Y., Sawada, M., Negishi, M., Suzumura, A., Marunouchi, T., Ichikawa, A., & Baba, A. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)00225-4 · Cited by 43
Obara, Y., Kurose, H., & Nakahata, N. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012922 · Cited by 42
Self-citationThe Identification and Characterization of Oligodendrocyte Thromboxane A2 Receptors
Blackman, S. C., Dawson, G., Antonakis, K., & Breton, G. C. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.475 · Cited by 41
Thériault, C., Rochdi, M. D., & Parent, J. (2004) · Biochemistry · doi:10.1021/bi036268v · Cited by 39
Dogné, J., de Leval, X., Benoit, P., Delarge, J., & Masereel, B. (2002) · American Journal of Respiratory Medicine · doi:10.1007/bf03257158 · Cited by 39
Minuz, P., Fumagalli, L., Gaino, S., Tommasoli, R., Degan, M., Cavallini, C., Lecchi, A., Cattaneo, M., Santonastaso, C. L., & Berton, G. (2006) · Biochemical Journal · doi:10.1042/bj20061015 · Cited by 38
Laroche, G., Rochdi, M. D., Laporte, S. A., & Parent, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414071200 · Cited by 37
Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change
Honma, S., Saika, M., Ohkubo, S., Kurose, H., & Nakahata, N. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.062 · Cited by 37
Self-citationMiller, A. M., Masrorpour, M., Klaus, C., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.026 · Cited by 35
Rolin, S., Dogné, J., Michaux, C., Delarge, J., & Masereel, B. (2001) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0290 · Cited by 35
Structure and function of prostanoid receptors.
Narumiya, S., Hirata, N., Namba, T., et al. (1993) · PubMed · Cited by 35
Liel, N., Nathan, I., Yermiyahu, T., ZOLOTOV, Z., Lieberman, J. R., Dvilansky, A., & Halushka, P. V. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90126-9 · Cited by 33
Murakami, Y., Yokotani, K., Okuma, Y., & Osumi, Y. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00133-x · Cited by 33
Okada, S., Murakami, Y., & Yokotani, K. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01629-7 · Cited by 32
Harenberg, A., Girkontaitė, I., Giehl, K., & Fischer, K. (2005) · European Journal of Immunology · doi:10.1002/eji.200425769 · Cited by 31
The Role of N-Glycosylation of Human Thromboxane A2Receptor in Ligand Binding
Chiang, N., & Tai, H. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0620 · Cited by 30
Palmitoylation of the TPβ isoform of the human thromboxane A2 receptor.
Reid, H. M., & Kinsella, B. T. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.001 · Cited by 29
Physiological Significance of Thromboxane A2 Receptor Dimerization
Sasaki, M., Miyosawa, K., Ohkubo, S., & Nakahata, N. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050839 · Cited by 29
Self-citationPharmacology of the Thromboxane Receptor Antagonist and Thromboxane Synthase Inhibitor BM‐531
Dogné, J., Rolin, S., de Leval, X., Benoit, P., Neven, P., Delarge, J., Kolh, P. H., Damas, J., David, J., & Masereel, B. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00057.x · Cited by 29
The G12 Family of G Proteins as a Reporter of Thromboxane A2 Receptor Activity
Zhang, L., DiLizio, C., Kim, D. S., Smyth, E. M., & Manning, D. R. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019703 · Cited by 28
Kelley, L. P., & Kinsella, B. T. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705695 · Cited by 27
Oketani, K., Nagakura, N., Harada, K., & Inoue, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01022-6 · Cited by 26
Kelley, L. P., & Kinsella, B. T. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00059-x · Cited by 23
Identification and functional characterization of thromboxane A2 receptors in Schwann cells
Muja, N., Blackman, S. C., Breton, G. C. L., & DeVries, G. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00378.x · Cited by 22
LeDuc, L. E., Wyche, A. A., Sprecher, H. W., Sankarappe, S. K., & Needleman, P. (1981) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13470-6 · Cited by 20
Cardiopulmonary responses to HCl infusion are mediated by thromboxane A2 but not by serotonin
Orr, J. A., Ernst, M., Carrithers, J. A., & Shirer, H. W. (1990) · Respiration Physiology · doi:10.1016/0034-5687(90)90084-c · Cited by 14
Geoffroy, J., Benzoni, D., & Sassard, J. (1989) · Journal of Hypertension · doi:10.1097/00004872-198900076-00132 · Cited by 14
Human bronchial smooth muscle cell proliferation via thromboxane A2 receptor
Suzuki, Y., Asano, K., Shiraishi, Y., et al. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.07.004 · Cited by 13
Nigam, S., Eskafi, S., Roscher, A., & Weitzel, H. K. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81744-k · Cited by 9
Mass-dependent signaling between G protein coupled receptors
Huang, J., Dong, L., & Breton, G. C. L. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.06.011 · Cited by 8
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Woodward, D. F., Jones, R. L., & Narumiya, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003517 · Cited by 443
Platelet receptors and signaling in the dynamics of thrombus formation
Rivera, J., Lozano, M. L., Navarro-Nunez, L., & Vicente, V. (2009) · Haematologica · doi:10.3324/haematol.2008.003178 · Cited by 416
Endothelium‐mediated control of vascular tone: COX‐1 and COX‐2 products
Félétou, M., Huang, Y., & Vanhoutte, P. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01276.x · Cited by 372
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Metadata
- Authors
- Nakahata, N.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 118
- Issue
- 1
- Pages
- 18-35
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2092296830
- Cited by
- 443
- References
- 116
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.